Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)
1. In patients with atrial fibrillation and advanced chronic kidney disease (CKD) not receiving dialysis, apixaban (Eliquis) was associated with ...






